← Back to patent-cliff list
替米沙坦
Tier C — Watch / tradeTelmisartan
Boehringer Ingelheim International Gmbh
Originator
1998
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：AT1
Brand：Telma、Kinzalmono、Micardis、Kinzal、美卡素、Telminone、Pritor、Kinzal/Pritor
Indications (approved)：高血压
Regional status
US
临床二期
2005-02-01
EU
批准上市
1998-12-11
China
批准上市
2000-12-15
Japan
批准上市
2004-08-27
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Telmisartan?
Approved indications include: 高血压.
When does the Telmisartan patent expire?
No public expiry year is available for Telmisartan yet; this page updates once verified.
How do I get a quote for Telmisartan intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25